{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:19:16Z","timestamp":1783948756957,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hungarian National Research Fund","award":["OTKA CK 80842"],"award-info":[{"award-number":["OTKA CK 80842"]}]},{"name":"Hungarian National Research Fund","award":["OTKA 77892"],"award-info":[{"award-number":["OTKA 77892"]}]},{"name":"Hungarian Neuroimaging Foundation","award":["TAMOP 4.2.2.A-11"],"award-info":[{"award-number":["TAMOP 4.2.2.A-11"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.molimm.2013.09.010","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T16:02:39Z","timestamp":1382803359000},"page":"200-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission"],"prefix":"10.1016","volume":"57","author":[{"given":"N\u00f3ra","family":"Veszeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"F\u00fcst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorottya","family":"Csuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Trauninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Bors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Rozsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita","family":"Jobb\u00e1gy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korn\u00e9lia","family":"Eizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-9852","authenticated-orcid":false,"given":"Lilian","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3864","key":"10.1016\/j.molimm.2013.09.010_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.163.3864.286","article-title":"Human C\u20323: evidence for the liver as the primary site of synthesis","volume":"163","author":"Alper","year":"1969","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molimm.2013.09.010_bib0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0090-1229(80)90169-5","article-title":"Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, alpha 1-antitrypsin, C8, and factor B","volume":"16","author":"Alper","year":"1980","journal-title":"Clinical Immunology and Immunopathology"},{"issue":"1\u20132","key":"10.1016\/j.molimm.2013.09.010_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2012.09.010","article-title":"Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid","volume":"254","author":"Asgari","year":"2013","journal-title":"Journal of Neuroimmunology"},{"issue":"5","key":"10.1016\/j.molimm.2013.09.010_bib0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.molimm.2013.09.010_bib0025","article-title":"The complement and immunoglobulin levels in NMO patients","author":"Chen","year":"2013","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"9","key":"10.1016\/j.molimm.2013.09.010_bib0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.molimm.2013.09.010_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2011.01.003","article-title":"Parameters of the classical complement pathway predict disease severity in hereditary angioedema","volume":"139","author":"Csuka","year":"2011","journal-title":"Clinical Immunology"},{"issue":"1\u20132","key":"10.1016\/j.molimm.2013.09.010_bib0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(88)90160-3","article-title":"An ELISA technique for the measurement of C1q in cerebrospinal fluid","volume":"114","author":"Delamarche","year":"1988","journal-title":"Journal of Immunological Methods"},{"issue":"3","key":"10.1016\/j.molimm.2013.09.010_bib0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1352458508099139","article-title":"Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody","volume":"15","author":"Doi","year":"2009","journal-title":"Multiple Sclerosis"},{"issue":"6","key":"10.1016\/j.molimm.2013.09.010_bib0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/009841096161564","article-title":"Acute-phase response in rat to carbon tetrachloride-azathioprine induced cirrhosis and partial hepatectomy of cirrhotic liver","volume":"47","author":"Fouad","year":"1996","journal-title":"Journal of Toxicology and Environmental Health"},{"issue":"24","key":"10.1016\/j.molimm.2013.09.010_bib0055","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"issue":"3\u20134","key":"10.1016\/j.molimm.2013.09.010_bib0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.molimm.2012.12.018","article-title":"Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE","volume":"54","author":"Hu","year":"2013","journal-title":"Molecular Immunology"},{"issue":"3","key":"10.1016\/j.molimm.2013.09.010_bib0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1759-1961.2010.00011.x","article-title":"Pathogenesis, diagnosis and treatment of neuromyelitis optica: changing concept of an old disease","volume":"1","author":"Illes","year":"2010","journal-title":"Clinical and Experimental Neuroimmunology"},{"issue":"7","key":"10.1016\/j.molimm.2013.09.010_bib0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nature Reviews Neurology"},{"issue":"Pt. 11","key":"10.1016\/j.molimm.2013.09.010_bib0075","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain: A Journal of Neurology"},{"issue":"10","key":"10.1016\/j.molimm.2013.09.010_bib0080","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archneurol.2010.269","article-title":"Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica","volume":"67","author":"Kalluri","year":"2010","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/j.molimm.2013.09.010_bib0085","first-page":"623","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochemical and biophysical research communications","volume":"386","author":"Kinoshita","year":"2009"},{"issue":"1\u20132","key":"10.1016\/j.molimm.2013.09.010_bib0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","article-title":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica","volume":"254","author":"Kuroda","year":"2013","journal-title":"Journal of Neuroimmunology"},{"issue":"9451","key":"10.1016\/j.molimm.2013.09.010_bib0095","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.molimm.2013.09.010_bib0100","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1096\/fj.10-177279","article-title":"Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation","volume":"25","author":"Li","year":"2011","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"Pt. 7","key":"10.1016\/j.molimm.2013.09.010_bib0105","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain: A Journal of Neurology"},{"issue":"8","key":"10.1016\/j.molimm.2013.09.010_bib0110","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI200318384","article-title":"Azathioprine: old drug, new actions","volume":"111","author":"Maltzman","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"Pt. 5","key":"10.1016\/j.molimm.2013.09.010_bib0115","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain: A Journal of Neurology"},{"issue":"4","key":"10.1016\/j.molimm.2013.09.010_bib0120","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1172\/JCI110687","article-title":"Complement biosynthesis by the human hepatoma-derived cell line HepG2","volume":"70","author":"Morris","year":"1982","journal-title":"Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.molimm.2013.09.010_bib0125","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.4049\/jimmunol.165.10.5867","article-title":"Attenuation of experimental autoimmune demyelination in complement-deficient mice","volume":"165","author":"Nataf","year":"2000","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.molimm.2013.09.010_bib0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Verkman AS. Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurology"},{"issue":"9","key":"10.1016\/j.molimm.2013.09.010_bib0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nature Immunology"},{"issue":"Pt. 5","key":"10.1016\/j.molimm.2013.09.010_bib0140","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain: A Journal of Neurology"},{"issue":"7","key":"10.1016\/j.molimm.2013.09.010_bib0145","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1468-1331.2009.02634.x","article-title":"Long-term effects of combined immunosuppressive treatment on myasthenic crisis","volume":"16","author":"Rozsa","year":"2009","journal-title":"European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies"},{"issue":"Pt. 2","key":"10.1016\/j.molimm.2013.09.010_bib0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain: A Journal of Neurology"},{"issue":"8","key":"10.1016\/j.molimm.2013.09.010_bib0155","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","article-title":"EFNS guidelines on diagnosis and management of neuromyelitis optica","volume":"17","author":"Sellner","year":"2010","journal-title":"European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies"},{"issue":"12","key":"10.1016\/j.molimm.2013.09.010_bib0160","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1016\/j.molimm.2007.02.002","article-title":"Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease","volume":"44","author":"Szalai","year":"2007","journal-title":"Molecular Immunology"},{"issue":"Pt. 5","key":"10.1016\/j.molimm.2013.09.010_bib0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain: A Journal of Neurology"},{"issue":"5","key":"10.1016\/j.molimm.2013.09.010_bib0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0145-305X(01)00089-1","article-title":"Conservation of the modular structure of complement factor I through vertebrate evolution","volume":"26","author":"Terado","year":"2002","journal-title":"Developmental and Comparative Immunology"},{"issue":"8","key":"10.1016\/j.molimm.2013.09.010_bib0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"1\u20132","key":"10.1016\/j.molimm.2013.09.010_bib0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jneuroim.2010.11.010","article-title":"Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients","volume":"233","author":"Tuzun","year":"2011","journal-title":"Journal of Neuroimmunology"},{"issue":"3","key":"10.1016\/j.molimm.2013.09.010_bib0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1084\/jem.151.3.501","article-title":"Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes","volume":"151","author":"Whaley","year":"1980","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"10.1016\/j.molimm.2013.09.010_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2249.1990.tb05227.x","article-title":"C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus","volume":"80","author":"Wild","year":"1990","journal-title":"Clinical and Experimental Immunology"},{"issue":"3","key":"10.1016\/j.molimm.2013.09.010_bib0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/WCO.0b013e3280be58d8","article-title":"Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis","volume":"20","author":"Wingerchuk","year":"2007","journal-title":"Current Opinion in Neurology"},{"issue":"10","key":"10.1016\/j.molimm.2013.09.010_bib0200","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589013005269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589013005269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T05:23:45Z","timestamp":1539235425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589013005269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0161589013005269"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2013.09.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}